127 related articles for article (PubMed ID: 2632142)
1. Biochemical, morphological and stereological study of the dermis in three members of a large family with type IV Ehlers-Danlos syndrome.
Vitellaro-Zuccarello L; Dyne K; Cetta G
Connect Tissue Res; 1989; 23(1):1-17. PubMed ID: 2632142
[TBL] [Abstract][Full Text] [Related]
2. Ehlers-Danlos syndrome type VIII: biochemical, stereological and immunocytochemical studies on dermis from a child with clinical signs of Ehlers-Danlos syndrome and a family history of premature loss of permanent teeth.
Dyne KM; Vitellaro-Zuccarello L; Bacchella L; Lanzi G; Cetta G
Br J Dermatol; 1993 Apr; 128(4):458-63. PubMed ID: 8494762
[TBL] [Abstract][Full Text] [Related]
3. Pathomorphological and biochemical alterations in Ehlers-Danlos-syndrome type IV.
Nerlich AG; Stöss H; Lehmann H; Krieg T; Müller PK
Pathol Res Pract; 1994 Aug; 190(7):697-706; discussion 706-7. PubMed ID: 7808968
[TBL] [Abstract][Full Text] [Related]
4. Ehlers-Danlos syndrome type IV D: an autosomal recessive disorder.
Sulh HM; Steinmann B; Rao VH; Dudin G; Zeid JA; Slim M; Der Kaloustian VM
Clin Genet; 1984 Mar; 25(3):278-87. PubMed ID: 6705261
[TBL] [Abstract][Full Text] [Related]
5. Low levels of serum type III procollagen aminoterminal propeptide confirmed type III collagen deficiency in patients without typical clinical symptoms of Ehlers-Danlos type IV.
Dyne KM; Zanaboni G; Annoni G; De Agostini MP; Cetta G
Eur J Clin Invest; 1989 Aug; 19(4):362-6. PubMed ID: 2506053
[TBL] [Abstract][Full Text] [Related]
6. Lung collagen in type IV Ehlers-Danlos syndrome: ultrastructural and biochemical studies.
Clark JG; Kuhn C; Uitto J
Am Rev Respir Dis; 1980 Dec; 122(6):971-8. PubMed ID: 7458068
[TBL] [Abstract][Full Text] [Related]
7. Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts.
Byers PH; Holbrook KA; Barsh GS; Smith LT; Bornstein P
Lab Invest; 1981 Apr; 44(4):336-41. PubMed ID: 6259441
[TBL] [Abstract][Full Text] [Related]
8. Clinical and ultrastructural heterogeneity of type IV Ehlers-Danlos syndrome.
Byers PH; Holbrook KA; McGillivray B; MacLeod PM; Lowry RB
Hum Genet; 1979 Mar; 47(2):141-50. PubMed ID: 437782
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and immunological studies of fibroblasts derived from a patient with Ehlers-Danlos syndrome type IV. Demonstrate reduced type III collagen synthesis.
Aumailley M; Krieg T; Dessau W; Müller PK; Timpl R; Bricaud H
Arch Dermatol Res; 1980; 269(2):169-77. PubMed ID: 7458408
[TBL] [Abstract][Full Text] [Related]
10. Clinical, ultrastructural and biochemical studies in two sibs with Ehlers-Danlos syndrome type VI-B-like features.
Oğur G; Baykan N; De Paepe A; Steinmann B; Quatacker J; Kuseyrí F; Yüksel-Apak M
Clin Genet; 1994 Dec; 46(6):417-22. PubMed ID: 7889658
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the COL3A1 gene result in the Ehlers-Danlos syndrome type IV and alterations in the size and distribution of the major collagen fibrils of the dermis.
Smith LT; Schwarze U; Goldstein J; Byers PH
J Invest Dermatol; 1997 Mar; 108(3):241-7. PubMed ID: 9036918
[TBL] [Abstract][Full Text] [Related]
12. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.
Smith LT; Wertelecki W; Milstone LM; Petty EM; Seashore MR; Braverman IM; Jenkins TG; Byers PH
Am J Hum Genet; 1992 Aug; 51(2):235-44. PubMed ID: 1642226
[TBL] [Abstract][Full Text] [Related]
13. Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen.
Pyeritz RE; Stolle CA; Parfrey NA; Myers JC
Am J Med Genet; 1984 Nov; 19(3):607-22. PubMed ID: 6507506
[TBL] [Abstract][Full Text] [Related]
14. Impaired secretion of type III procollagen in Ehlers-Danlos syndrome type IV fibroblasts: correction of the defect by incubation at reduced temperature and demonstration of subtle alterations in the triple-helical region of the molecule.
Superti-Furga A; Steinmann B
Biochem Biophys Res Commun; 1988 Jan; 150(1):140-7. PubMed ID: 3337712
[TBL] [Abstract][Full Text] [Related]
15. Ehlers-Danlos syndrome type I: a clinical and ultrastructural study of a family with reduced amounts of collagen type III.
De Paepe A; Nicholls A; Narcisi P; De Keyser F; Quatacker J; Van Staey M; Matton M; Pope FM
Br J Dermatol; 1987 Jul; 117(1):89-97. PubMed ID: 3651336
[TBL] [Abstract][Full Text] [Related]
16. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I].
Sokolov BP; Sher BM; Lomova TIu; Kukharenko VI; Blinnikova OE
Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV.
Nuytinck L; Narcisi P; Nicholls A; Renard JP; Pope FM; De Paepe A
J Med Genet; 1992 Jun; 29(6):375-80. PubMed ID: 1619632
[TBL] [Abstract][Full Text] [Related]
18. Defects in the processing of procollagen to collagen are demonstrable in cultured fibroblasts from patients with the Ehlers-Danlos and osteogenesis imperfecta syndromes.
Minor RR; Sippola-Thiele M; McKeon J; Berger J; Prockop DJ
J Biol Chem; 1986 Jul; 261(21):10006-14. PubMed ID: 3733683
[TBL] [Abstract][Full Text] [Related]
19. Biochemical characteristics of Ehlers-Danlos syndrome type VI in a family with one affected infant.
Krieg T; Feldmann U; Kessler W; Müller PK
Hum Genet; 1979 Jan; 46(1):41-9. PubMed ID: 429005
[TBL] [Abstract][Full Text] [Related]
20. Ehlers-Danlos syndrome. A variant characterized by the deficiency of pro alpha 2 chain of type I procollagen.
Sasaki T; Arai K; Ono M; Yamaguchi T; Furuta S; Nagai Y
Arch Dermatol; 1987 Jan; 123(1):76-9. PubMed ID: 3800425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
